Renda Li
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 6
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 3
- Co-authors
- Yibo Gao (14 shared papers)Wei Guo (8 shared papers)Fei Shao (6 shared papers)Zhenlin Yang (9 shared papers)Jie He (7 shared papers)Fengwei Tan (10 shared papers)Jie He (5 shared papers)Shugeng Gao (7 shared papers)
- Journals
- Molecular Pharmaceutics (2 papers)Nature Communications (2 papers)Frontiers in Immunology (2 papers)Frontiers in Oncology (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Renda Li
24 papers receiving 674 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 264
- Oncology 257
- Pulmonary and Respiratory Medicine 232
- Molecular Biology 391
- Immunology 89
Countries citing papers authored by Renda Li
This map shows the geographic impact of Renda Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renda Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renda Li more than expected).
Fields of papers citing papers by Renda Li
This network shows the impact of papers produced by Renda Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renda Li. The network helps show where Renda Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Renda Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 123 | |
| 2 | 2020 | 90 | |
| 3 | 2021 | 70 | |
| 4 | 2017 | 59 | |
| 5 | 2022 | 45 | |
| 6 | 2020 | 42 | |
| 7 | 2022 | 32 | |
| 8 | 2021 | 29 | |
| 9 | 2019 | 25 | |
| 10 | 2021 | 22 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 18 | |
| 13 | 2022 | 17 | |
| 14 | 2023 | 16 | |
| 15 | 2021 | 15 | |
| 16 | 2023 | 14 | |
| 17 | 2021 | 12 | |
| 18 | 2023 | 10 | |
| 19 | 2022 | 10 | |
| 20 | 2024 | 5 |
About Renda Li
Renda Li is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 26 papers that have together received 681 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer, Lipids, and Metabolism (4 papers), Lung Cancer Treatments and Mutations (4 papers), Ferroptosis and cancer prognosis (3 papers), Lung Cancer Research Studies (3 papers), Metastasis and carcinoma case studies (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (264 citations), Oncology (257 citations), Pulmonary and Respiratory Medicine (232 citations), Molecular Biology (391 citations) and Immunology (89 citations). Renda Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yibo Gao, Wei Guo, Fei Shao, Zhenlin Yang, Jie He, Fengwei Tan, Jie He, Shugeng Gao, Sijin Sun and Hao Zhang. Their work appears in journals such as Molecular Pharmaceutics, Nature Communications, Frontiers in Immunology, Frontiers in Oncology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.